| Drug Name | Fabrazyme®(agalsidase beta) |
|---|---|
| Drug Class | |
| Risk minimization type |
Other
|
| Specialty (Theraputic area) | |
| Risk |
guidance to HCP and patients for the management of patient receiving Fabrazyme |
| other |
Home Infusion HCP Manual
Home Infusion Patient Manual
Home Infusion Patient Manual Arabic |